No Data
No Data
No Data
No Data
No Data
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
Yahoo FinanceApr 30 22:01
Halozyme Therapeutics Insider Lowered Holding By 62% During Last Year
Looking at Halozyme Therapeutics, Inc.'s (NASDAQ:HALO ) insider transactions over the last year, we can see that insiders were net sellers. That is, there were more number of shares sold by insiders t
Simply Wall StApr 26 21:53
Press Release: Mahesh Krishnan Elected to Halozyme's Board of Directors
Mahesh Krishnan Elected to Halozyme's Board of Directors PR Newswire SAN DIEGO, April 25, 2024 SAN DIEGO, April 25, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") toda
Dow JonesApr 26 04:45
Halozyme to Report First Quarter 2024 Financial and Operating Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its first quarter 2024 financial and operating results on...
PR NewswireApr 23 20:30
Halozyme Therapeutics (HALO) Is an Incredible Growth Stock: 3 Reasons Why
Yahoo FinanceApr 19 00:45
Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know
Yahoo FinanceApr 19 00:00
No Data
No Data